002562 Brother Enterprises Holding
- 2.85
- -0.13-4.36%
Brother Enterprises Holding News
Brother Enterprises Holding's Q1 2024 financial report analysis: net income declined, improved cash flow situation.
Brother Enterprises Holding (Stock Code: 002562) recently released its Q1 2024 financial report. As a focus of market attention, the report details the company's financial condition and business performance during the reporting period. Here is an in-depth interpretation of Brother Enterprises Holding's Q1 report. First, we focus on the company's asset and liability data. The report shows that the total assets at the end of this reporting period were 5.843 billion yuan, slightly down from the end of the previous year, a decrease of 0.75%. This is mainly due to the structural adjustment of the company's liabilities and equity. In terms of liabilities, although the total amount of liabilities at the end of the period was 2.817 billion yuan, a decrease from the beginning of the period, but...
Brother Enterprises' Unit Gets Nod to Market Iopamidol in Europe
Brother Enterprises Holding's (SHE:002562) unit, Jiangxi Brother Pharmaceutical, obtained the suitability certificate suitability from the European Directorate for the Quality of Medicines & HealthCar
Brother Technology (002562.SZ): Does not involve chemical synthesis of polyether ether ketone
Gelonghui, May 20 | Brother Technology (002562.SZ) said on the investor interactive platform that the company is not involved in the chemical synthesis of polyether ether ketone. Polyether ether ketone is a key application area for hydroquinone, and the company is still in the promotion stage.
Brother Technology (002562.SZ): Terminate the construction project with an annual output of 30,000 tons of natural flavors
Gelonghui, May 13, 丨 Brother Technology (002562.SZ) announced that the company held the 8th meeting of the 6th board of directors on May 11, 2024 to review and pass the “Proposal on Termination of the Construction Project with an Annual Output of 30,000 Tons of Natural Fragrances”. Up to now, with the completion and commissioning of the second phase of the hydroquinol project, the company's fragrance division has relatively abundant production capacity. Based on the current development plan, the company will focus on existing products and markets in the hydroquinone industry chain in the short term. While strengthening the advantages of large-scale production, the company will fully tap existing production capacity potential, continue to explore potential markets and customers, and accelerate the release of existing production capacity.
Does Brother Enterprises HoldingLtd (SZSE:002562) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much
Brother Technology (002562.SZ): Net loss of 25.2 million yuan in the first quarter turned into a year-on-year loss
Gelonghui, April 29 | Brother Technology (002562.SZ) released its first quarter report. Operating revenue was 800 million yuan, up 21.1% year on year, net loss of 25.2 million yuan, turning loss year on year. After deducting non-net loss of 257.975 million yuan, basic earnings per share -0.0237 yuan.
Brother Technology (002562.SZ) issued a forecast loss. The net loss for the first quarter is expected to be 20 million yuan to 26 million yuan, changing from profit to loss over the previous year
Brother Technology (002562.SZ) released a performance forecast for the first quarter of 2024, which is expected to be owned by a listed company...
Brother Technology (002562.SZ): Hydroquinone is mainly used as a polymerization inhibitor in the petrochemical field
Gelonghui, April 10 | Brother Technology (002562.SZ) said on the investor interactive platform that the hydroquinone produced by the company is mainly used in the fields of polymerization inhibitors in the petrochemical industry, anti-aging agents in the rubber industry, and food antioxidants.
Brother Technology (002562.SZ): Hydroquinone products are now fully sold to mainstream domestic acrylic acid manufacturers
Gelonghui, April 10 | Brother Technology (002562.SZ) said on the investor interactive platform that the company's hydroquinone products are now fully sold to mainstream domestic acrylic acid producers.
Brother Enterprises HoldingLtd's (SZSE:002562) Earnings Have Declined Over Five Years, Contributing to Shareholders 49% Loss
Brother Enterprises Holding Co.,Ltd. (SZSE:002562) shareholders should be happy to see the share price up 12% in the last month. But over the last half decade, the stock has not performed well. In
Brother Technology (002562.SZ): Currently, some products in the company's pharmaceutical sector involve cooperation with CRO companies
Gelonghui, March 12: An investor asked Brother Technology (002562.SZ) on the investor interactive platform, “Does the company involve the CXO concept?” The company replied that currently some products in the company's pharmaceutical sector involve cooperation with CRO companies, and in the future, the pharmaceutical sector will gradually develop the CMO/CDMO business for APIs and formulations.
Brother Technology (002562.SZ): Some of the company's products have entered the Indian market
On March 8, GLONGHUI | Brother Technology (002562.SZ) said on the investor interactive platform that some of the company's products have entered the Indian market and will continue to increase the promotion and layout of the global market in the future.
Returns On Capital At Brother Enterprises HoldingLtd (SZSE:002562) Paint A Concerning Picture
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a business will show two trends; firstly a growing return on capital employed (ROC
Brother Technology (002562.SZ): Wholly-owned subsidiary once again approved as a high-tech enterprise
Gelonghui, Feb. 2: Brother Technology (002562.SZ) announced that its wholly-owned subsidiary Jiangxi Brother Pharmaceutical Co., Ltd. recently received a “High-tech Enterprise Certificate” jointly issued by the Jiangxi Provincial Department of Science and Technology, the Jiangxi Provincial Department of Finance, and the Jiangxi Provincial Taxation Bureau of the State Administration of Taxation. The certificate number is GR202336001070. The date of issue is November 22, 2023, and is valid for three years. This is a re-certification carried out after the expiration of Brother Pharmaceuticals's original high-tech enterprise certificate.
Brother Technology (002562.SZ): Expected net loss of 150 million yuan to 190 million yuan in 2023
On January 30, GLONGHUI | Brother Technology (002562.SZ) announced that it expects a net loss of 150,000,000 yuan to 190.01 million yuan in 2023, after deducting non-net loss of 210,000 yuan to 250,000 yuan. During the reporting period, due to market changes and industry cyclicality, sales prices of the company's vitamins, flavors, chromium salts and other related products declined, and product gross margin declined, leading to a loss in the company's 2023 performance. During the reporting period, the company's non-recurring revenue was mainly due to receiving dividends and interest from Jiaxing Zhonghua Chemical Co., Ltd. 4,13
Improved Revenues Required Before Brother Enterprises Holding Co.,Ltd. (SZSE:002562) Shares Find Their Feet
You may think that with a price-to-sales (or "P/S") ratio of 1.3x Brother Enterprises Holding Co.,Ltd. (SZSE:002562) is a stock worth checking out, seeing as almost half of all the Chemicals companies
Brother Technology (002562.SZ): Subsidiary obtains CEP certificate for APIs
Gelonghui, January 21丨Brother Technology (002562.SZ) announced that Jiangxi Brother Pharmaceutical Co., Ltd. (“Brother Pharmaceuticals”), a wholly-owned subsidiary of the company, recently received the European Pharmacopeia applicability certificate (“CEP certificate”) issued by the European Drug Quality Administration. Iohexol is widely used in angiography, subarachnography, coronary angiography, spinal cord and hip joints, urinary system imaging, CT enhanced scanning, etc., and has the advantages of low osmotic pressure, low neurotoxicity, low contrast density, and good tolerability. Currently, the global market demand for iohexol APIs is expected to be around 5,00
Brother Technology (002562.SZ): The company's chromium salt products have cooperated with some pigment customers
Gelonghui, January 17丨Brother Technology (002562.SZ) said on the investor interactive platform that the company's chromium salt products have cooperated with some pigment customers, and the company will further actively explore the market in the future
[BT Financial Report Momentary Analysis] Brother Technology's 2023 Quarterly Report: An Industry Leader Where Challenges and Opportunities Coexist
As a world-renowned enterprise focusing on pharmaceuticals, food and specialty chemicals, Brother Technology (stock code: 002562) has become a resounding name in the industry due to its leading position in vitamins and leather chemicals, as well as its active layout in the fields of flavors, fragrances, and pharmaceuticals. The company always insists on being customer-centered, providing high-quality products and services, and specialized solutions, and is committed to becoming a leading enterprise in its main business field. In terms of assets and liabilities, Brother Technology's total assets increased from 5.699 billion yuan at the end of the previous year to 5.805 billion yuan at the end of the reporting period, an increase of 1
Brother Technology (002562.SZ): Currently has four production sites
Gelonghui, January 15 | Brother Technology (002562.SZ) said on the investor interactive platform that the company is headquartered in Haining, Zhejiang, and currently has four production bases, including a base in Haining in Zhejiang, a base in Yancheng in Jiangsu, a base in Jiujiang in Jiangxi, and a base in South Africa.
Analysis
Price Target
No Data
